J-113397
Based on 1 Customer Validation
J-113397 is the first potent and selective nonpeptidyl ORL1 receptor antagonist (Ki: cloned human ORL1=1.8 nM) without any agonistic effects on other opioid receptors.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 99.95%
- CAS 番号: 256640-45-6
- 分子式: C24H37N3O2
- 分子量:399.57
-
保管条件:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
-
溶剤 & 溶解度
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
Opioid Receptor アイソフォーム固有の製品をすべて表示
More
生物活性
|
NOP Receptor/ORL1 1.8 ± 0.24 nM (Ki) |
κ Opioid Receptor/KOR 640 ± 87 nM (Ki) |
μ Opioid Receptor/MOR 1000 ± 160 nM (Ki) |
δ Opioid Receptor/DOR >10000 nM (Ki) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CHO | EC50 |
>10 μM
Compound: J-113397 (3R,4R)
|
Agonistic activity against nociceptin produced GTPgammaS binding to Opioid receptor like 1 expressed in CHO cells
Agonistic activity against nociceptin produced GTPgammaS binding to Opioid receptor like 1 expressed in CHO cells
|
[PMID: 10602690] |
| CHO | IC50 |
1400 nM
Compound: J-113397 (3R,4R)
|
Binding affinity in CHO cells stably expressing cloned human Opioid receptor kappa 1 by displacing radioligand [3H]U-69593
Binding affinity in CHO cells stably expressing cloned human Opioid receptor kappa 1 by displacing radioligand [3H]U-69593
|
[PMID: 10602690] |
| CHO | IC50 |
2.3 nM
Compound: J-113397 (3R,4R)
|
Binding affinity in CHO cells stably expressing cloned human Opioid receptor like 1 by displacing radioligand [125I]Tyr14-nociceptin
Binding affinity in CHO cells stably expressing cloned human Opioid receptor like 1 by displacing radioligand [125I]Tyr14-nociceptin
|
[PMID: 10602690] |
| CHO | IC50 |
2200 nM
Compound: J-113397 (3R,4R)
|
Binding affinity in CHO cells stably expressing cloned human Opioid receptor mu 1 by displacing diprenorphine
Binding affinity in CHO cells stably expressing cloned human Opioid receptor mu 1 by displacing diprenorphine
|
[PMID: 10602690] |
| CHO | IC50 |
5.6 nM
Compound: J-113397 (3R,4R)
|
Antagonistic activity against nociceptin produced [35S]GTP-gamma-S, binding to Opioid receptor like 1 expressed in CHO cells
Antagonistic activity against nociceptin produced [35S]GTP-gamma-S, binding to Opioid receptor like 1 expressed in CHO cells
|
[PMID: 10602690] |
| CHO | IC50 |
>10000 nM
Compound: J-113397 (3R,4R)
|
Binding affinity in CHO cells stably expressing cloned human Opioid receptor delta 1 by displacing radioligand [3H][D-Ala2,D-Leu5]enkephalin
Binding affinity in CHO cells stably expressing cloned human Opioid receptor delta 1 by displacing radioligand [3H][D-Ala2,D-Leu5]enkephalin
|
[PMID: 10602690] |
| CHO | EC50 |
>10 μM
Compound: 1
|
Agonist activity on nociceptin-induced maximal [35S]GTP-gamma-S binding to ORL1 expressed in CHO cells
Agonist activity on nociceptin-induced maximal [35S]GTP-gamma-S binding to ORL1 expressed in CHO cells
|
[PMID: 16451050] |
| CHO | IC50 |
>10 μM
Compound: 1
|
Displacement of [3H]naltrindole from cloned human delta opioid receptor expressed in CHO cells
Displacement of [3H]naltrindole from cloned human delta opioid receptor expressed in CHO cells
|
[PMID: 16451050] |
| CHO | IC50 |
1.5 nM
Compound: 1
|
Antagonist activity on nociceptin-induced [35S]GTP-gamma-S binding to ORL1 expressed in CHO cells
Antagonist activity on nociceptin-induced [35S]GTP-gamma-S binding to ORL1 expressed in CHO cells
|
[PMID: 16451050] |
| CHO | IC50 |
1600 nM
Compound: 1
|
Displacement of [3H]U-69593 from cloned human kappa opioid receptor expressed in CHO cells
Displacement of [3H]U-69593 from cloned human kappa opioid receptor expressed in CHO cells
|
[PMID: 16451050] |
| CHO | IC50 |
2.4 nM
Compound: 1
|
Displacement of [125I]Tyr-nociceptin from cloned human ORL1 expressed in CHO cells
Displacement of [125I]Tyr-nociceptin from cloned human ORL1 expressed in CHO cells
|
[PMID: 16451050] |
| CHO | IC50 |
3400 nM
Compound: 1
|
Displacement of [3H]diprenorphin from cloned human mu opioid receptor expressed in CHO cells
Displacement of [3H]diprenorphin from cloned human mu opioid receptor expressed in CHO cells
|
[PMID: 16451050] |
| CHO | IC50 |
2.3 nM
Compound: 1, J-113397
|
Displacement of [125I]Tyr14-nociceptin from human cloned ORL1 receptor expressed in CHO cells
Displacement of [125I]Tyr14-nociceptin from human cloned ORL1 receptor expressed in CHO cells
|
[PMID: 19537798] |
J-113397 (0-500 nM) inhibits NociceptinNociceptin/orphanin FQ (HY-P0183)-stimulated [35S]GTPγS binding to CHO cells expressing ORL1 (CHO-ORL1) but had no effect on [35S]GTPγS binding by itself[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:CHO-ORL1 cells
-
Concentration:0, 0.1, 1, 10, 100, 200, 500 nM
-
Incubation Time:10 min
-
Result:Inhibited nociceptin/orphanin FQ-stimulated [35S]guanosine 5′-O-(γ-thio)triphosphate (GTPγS) binding to Chinese Hamster Ovary (CHO) cells expressing ORL1 (CHO-ORL1) with an IC50 value of 5.3 nM but had no effect on [35S]GTPγS binding by itself.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male ICR mice (15–25 g)[1]
-
Dosage:0, 3, 10, 30 mg/kg
-
Administration:Subcutaneously (s.c.), 10 min prior to administering 0.1 nmol nociceptin/orphanin FQ to the mice
-
Result:Dose-dependently inhibited hyperalgesia elicited by intracerebroventricular (i.c.v.) administration of nociceptin/orphanin FQ in a tail-flick test with mice.
化学情報
-
CAS 番号 256640-45-6
-
性状 Solid
-
分子量 399.57
-
分子式 C24H37N3O2
-
Color White to off-white
-
SMILES
O=C1N([C@H]2[C@@H](CN(CC2)CC3CCCCCCC3)CO)C4=CC=CC=C4N1CC
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
溶剤 & 溶解度
DMSO : 2 mg/mL (5.01 mM; Need ultrasonic and warming; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
純度とドキュメンテーション
-
データシート (279 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
取扱説明書 (2659 KB)
参考文献
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.5027 mL | 12.5135 mL | 25.0269 mL | 62.5673 mL |
| 5 mM | 0.5005 mL | 2.5027 mL | 5.0054 mL | 12.5135 mL |
J-113397 関連分類
HY-114072 関連分類
Powered by Bioz